{
    "root": "6055d9e4-262f-4fd2-995f-37f17894eeab",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "Hydrocodone Polistirex and Chlorpheniramine Polistirex",
        "suffix": {
            "text": "extended-release"
        }
    },
    "value": "20240730",
    "ingredients": [
        {
            "name": "HYDROCODONE BITARTRATE",
            "code": "NO70W886KK"
        },
        {
            "name": "CHLORPHENIRAMINE MALEATE",
            "code": "V1Q0O9OJ9Z"
        },
        {
            "name": "ASCORBIC ACID",
            "code": "PQ6CK8PD0R"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "HIGH FRUCTOSE CORN SYRUP",
            "code": "XY6UN3QB6S"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "POLYVINYL ACETATE",
            "code": "32K497ZK2U"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "SODIUM ASCORBATE",
            "code": "S033EH8359"
        },
        {
            "name": "SODIUM METABISULFITE",
            "code": "4VON5FNS3C"
        },
        {
            "name": "SODIUM POLYSTYRENE SULFONATE",
            "code": "1699G8679Z"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "XANTHAN GUM",
            "code": "TTV12P4NEE"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        }
    ],
    "indications": "hydrocodone polistirex chlorpheniramine polistirex extended-release suspension indicated temporary relief cough upper respiratory symptoms associated allergy common cold patients 18 years age older . important limitations : • indicated pediatric patients 18 years age [ ( 8.4 ) ] . • contraindicated pediatric patients less 6 years age [ ( 4 ) ] . • risks addiction , abuse , misuse opioids , even recommended doses [ ( 5.1 ) ] , reserve hydrocodone polistirex chlorpheniramine polistirex adult patients whomthe benefits cough suppression expected outweigh risks , adequateassessment etiology cough made .",
    "contraindications": "adults 18 years age older : 5 ml every 12 hours needed , exceed 2 doses ( 10 ml ) 24 hours . ( 2.2 ) measure hydrocodone polistirex chlorpheniramine polistirex accurate milliliter measuring device . ( 2.1 , 5.5 ) increase dose dosing frequency . ( 2.1 ) prescribe shortest duration consistent treatment goals . ( 2.3 ) reevaluate patients unresponsive cough 5 days sooner possible underlying pathology . ( 2.3 ) reevaluate patient prior refilling . ( 2.3 )",
    "warningsAndPrecautions": "hydrocodone polistirex chlorpheniramine polistirex extended-release suspension , equivalent 10 mg hydrocodone bitartrate 8 mg chlorpheniramine maleate per 5 ml , yellow viscous suspension , available : ndc 27808-086-01 4 fl . oz . bottle containing 115 ml suspension.ndc 27808-086-03 3 fl . oz . bottle containing 70 ml suspension.each bottle supplied dosing cup calibrated measuring 2.5 ml 5 ml doses.shake well . dispense entire bottle one unit . ndc 27808-086-02 16 fl . oz . bottle containing 473 ml suspension.shake well . dispense tight , light-resistant container , defined usp , child-resistant closure . light sensitive : protect light . store away direct sunlight . store 20°c 25°c ( 68°f 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature . ] ensure patients oral dosing dispenser measures appropriate volume milliliters . counsel patients utilize oral dosing dispenser correctly measure oral suspension prescribed .",
    "adverseReactions": "hydrocodone polistirex chlorpheniramine polistirex contraindicated : children younger 6 years age [ ( 5.2 , 5.3 ) , ( 8.4 ) ] . hydrocodone polistirex chlorpheniramine polistirex also contraindicated patients : significant respiratory depression [ ( 5.2 ) ] . acute severe bronchial asthma unmonitored setting absence resuscitative equipment [ ( 5.4 ) ] . known suspected gastrointestinal obstruction , including paralytic ileus [ ( 5.9 ) ] . hypersensitivity hydrocodone , chlorpheniramine , inactive ingredients hydrocodone polistirex chlorpheniramine polistirex [ ( 6 ) ] .",
    "indications_original": "Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension is indicated for the temporary relief of cough and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older.\n                  \n                     Important Limitations of Use:\n                  • Not indicated for pediatric patients under 18 years of age [see \n                           Use in Specific Populations (8.4\n                        \n                        )\n                     ].\n                  • Contraindicated in pediatric patients less than 6 years of age [see \n                     \n                        Contraindications (4)\n                     ].\n                  • Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see \n                     \n                        Warnings and Precautions (5.1)\n                     ], reserve Hydrocodone Polistirex and Chlorpheniramine Polistirex for use in adult patients for whomthe benefits of cough suppression are expected to outweigh the risks, and in whom an adequateassessment of the etiology of the cough has been made.",
    "contraindications_original": "Adults 18 years of age and older : 5 mL every 12 hours as needed, not to exceed 2 doses (10 mL) in 24 hours. ( 2.2 ) Measure Hydrocodone Polistirex and Chlorpheniramine Polistirex with an accurate milliliter measuring device. ( 2.1 , 5.5 ) Do not increase the dose or dosing frequency. ( 2.1 ) Prescribe for the shortest duration consistent with treatment goals. (2.3 ) Reevaluate patients with unresponsive cough in 5 days or sooner for possible underlying pathology. ( 2.3 ) Reevaluate patient prior to refilling. ( 2.3 )",
    "warningsAndPrecautions_original": "Hydrocodone Polistirex and Chlorpheniramine Polistirex  Extended-Release Suspension, equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL, is a  yellow viscous suspension, available as:\n                  NDC 27808-086-01 4 fl. oz. bottle containing 115 mL suspension.NDC 27808-086-03 3 fl. oz. bottle containing 70 mL suspension.Each bottle is supplied with a dosing cup calibrated for measuring 2.5 mL and 5 mL doses.Shake well. Dispense entire bottle as one unit.\n                  NDC 27808-086-02 16 fl. oz. bottle containing 473 mL suspension.Shake well. Dispense in a tight, light-resistant container, as defined in the USP, with a child-resistant closure.\n                  Light Sensitive: Protect from light. Store away from direct sunlight.\n                  Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature.]\n                  Ensure that patients have an oral dosing dispenser that measures the appropriate volume in milliliters. Counsel patients on how to utilize the oral dosing dispenser and correctly measure the oral suspension as prescribed.",
    "adverseReactions_original": "Hydrocodone Polistirex and Chlorpheniramine Polistirex is contraindicated for:\n                  \n                     \n                        All children younger than 6 years of age [see \n                                 Warnings and Precautions (5.2\n                              \n                           \n                           , \n                           \n                              5.3\n                           \n                           ), Use in Specific Populations (8.4)\n                           ].\n                     \n                  \n                  Hydrocodone Polistirex and Chlorpheniramine Polistirex is also contraindicated in patients with:\n                  \n                     \n                        Significant respiratory depression [see \n                           \n                              Warnings and Precautions (5.2)\n                           ].\n                     \n                     \n                        Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment[see \n                           \n                              Warnings and Precautions (5.4)\n                           ].\n                     \n                     \n                        Known or suspected gastrointestinal obstruction, including paralytic ileus [see \n                           \n                              Warnings and Precautions (5.9)\n                           ].\n                     \n                     \n                        Hypersensitivity to hydrocodone, chlorpheniramine, or any of the inactive ingredients in  Hydrocodone Polistirex and Chlorpheniramine Polistirex [see \n                           \n                              Adverse Reactions (6)\n                           ]."
}